ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      80.825
      -0.58%
      Bitcoin
      67,871.40
      0.22%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Perspective Therapeutics Inc (CATX)

      7. Perspective Therapeutics Inc (CATX) News

      CATX

      Perspective Therapeutics (CATX)

      Perspective Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:CATX
      DateTimeSourceHeadlineSymbolCompany
      05/24/20248:01AMGlobeNewswire Inc.Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsAMEX:CATXPerspective Therapeutics Inc
      05/20/20247:00AMGlobeNewswire Inc.Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024AMEX:CATXPerspective Therapeutics Inc
      05/15/20247:00AMGlobeNewswire Inc.Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 ResultsAMEX:CATXPerspective Therapeutics Inc
      05/03/20247:00AMGlobeNewswire Inc.Perspective Therapeutics to Participate at Upcoming May Investor ConferencesAMEX:CATXPerspective Therapeutics Inc
      05/02/20247:00AMGlobeNewswire Inc.Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial ResultsAMEX:CATXPerspective Therapeutics Inc
      04/30/20247:00AMGlobeNewswire Inc.Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETsAMEX:CATXPerspective Therapeutics Inc
      04/08/20248:00AMGlobeNewswire Inc.Perspective Therapeutics to Participate at Upcoming April Investor ConferencesAMEX:CATXPerspective Therapeutics Inc
      03/28/20247:30AMGlobeNewswire Inc.Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial ResultsAMEX:CATXPerspective Therapeutics Inc
      03/18/20248:00AMGlobeNewswire Inc.Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic MelanomaAMEX:CATXPerspective Therapeutics Inc
      03/11/20248:00AMGlobeNewswire Inc.Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024AMEX:CATXPerspective Therapeutics Inc
      03/05/20248:00AMGlobeNewswire Inc.Perspective Therapeutics Acquires CGMP-Compliant Manufacturing FacilityAMEX:CATXPerspective Therapeutics Inc
      03/04/20249:45AMGlobeNewswire Inc.Perspective Therapeutics Announces $87.4 Million Private PlacementAMEX:CATXPerspective Therapeutics Inc
      02/26/20248:00AMGlobeNewswire Inc.Perspective Therapeutics to Participate at Upcoming Investor ConferencesAMEX:CATXPerspective Therapeutics Inc
      02/12/20248:00AMGlobeNewswire Inc.Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceAMEX:CATXPerspective Therapeutics Inc
      01/22/20244:05PMGlobeNewswire Inc.Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private PlacementAMEX:CATXPerspective Therapeutics Inc
      01/18/20247:00AMGlobeNewswire Inc.Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private PlacementAMEX:CATXPerspective Therapeutics Inc
      01/17/20244:05PMGlobeNewswire Inc.Perspective Therapeutics Announces Proposed Public OfferingAMEX:CATXPerspective Therapeutics Inc
      01/17/20248:00AMGlobeNewswire Inc.Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01AMEX:CATXPerspective Therapeutics Inc
      01/09/20244:10PMAllPennyStocks.comAnother Healthcare Stock Stealing The ShowAMEX:CATXPerspective Therapeutics Inc
      01/09/20248:00AMGlobeNewswire Inc.Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing CapabilityAMEX:CATXPerspective Therapeutics Inc
      01/09/20248:00AMGlobeNewswire Inc.Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective TherapeuticsAMEX:CATXPerspective Therapeutics Inc
      01/05/20248:00AMGlobeNewswire Inc.Perspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer TreatmentAMEX:CATXPerspective Therapeutics Inc
      01/02/20248:00AMGlobeNewswire Inc.Perspective Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
      12/12/20238:00AMGlobeNewswire Inc.Perspective Therapeutics Divests Brachytherapy BusinessAMEX:CATXPerspective Therapeutics Inc
      12/07/20238:00AMGlobeNewswire Inc.Perspective Therapeutics Announces First Patient Dosed in a Phase 1 Study of [(212)Pb]VMT-α-NET to Treat Refractory or Relapsed Neuroendocrine TumorsAMEX:CATXPerspective Therapeutics Inc
      06/14/20234:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:CATXPerspective Therapeutics Inc
      06/14/20234:42PMEdgar (US Regulatory)Specialized Disclosure Report (sd)AMEX:CATXPerspective Therapeutics Inc
      06/06/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:CATXPerspective Therapeutics Inc
      05/15/20235:23PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:CATXPerspective Therapeutics Inc
      05/15/20235:16PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:CATXPerspective Therapeutics Inc
       Showing the most relevant articles for your search:AMEX:CATX